Looking to build compliant cleaning validation program and ensure that your next product is not affected by contamination? [Recording: 14 video sessions].

What is next in testing and analyzing for extractables and leachables in biopharmaceutical development and release? [Recording: 18 video sessions].

Learn the best techniques and cutting-edge methods for reducing genotoxic and elemental impurities in pharmaceutical products. [Recording: 17 video sessions].

Together with professionals in the field, explore the most recent developments in HPAPIs: Containment and Handling. [Recording: 18 video sessions].

Learn innovative techniques for analyzing and testing for extractables and leachables in biopharmaceutical development. [Recording: 20 video sessions].

Learn about best practices and innovative approaches to manage genotoxic and other mutagenic impurities control strategies. [Recording: 13 video sessions].

Explore the latest insights in safe HPAPIs handling together with leading occupational toxicologists and containment experts. [Recording: 15 video sessions].

What actions medical device manufacturers could take to strengthen the implementation strategy for EU MDR and IVDR? [Recording: 15 video sessions].

What is next in testing and analyzing for extractables and leachables in biopharmaceutical development and release? [Recording: 12 video sessions].